Antagonistic effects such as inhibition of EGF-dependent receptor phosphorylation, cell proliferation and tumor growth have been described for various EGFR-specific biparatopic molecules (Roovers et al. 2011; Heukers et al. 2013; Fan et al. 2021; Sharifi et al. 2021). This evidence concerns the gene EGFR and neoplasm.